Stock screenerAll disclosures →
EDGAR →
CRSP
Conviction 27HealthcareScan · Mon, Aug 10, 2026CRSP$53.50-0.05%
ResistanceSupportVol 14Insider sellVol MA14 1.59M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price53.50
Change-0.05%
Gap-0.04%
Rel volume0.96×
Avg volume1.6M
Avg $ vol79M
SMA 2049.34
SMA 5052.28
SMA 20053.49
Price vs 50+2.33%
Price vs 200+0.02%
MA stackmixed
50/200 cross—
Supertrenddown · 54.20
RSI (14)58
MACD hist0.80
MACD crossbull · 5d
Stoch %K / %D87 / 85
ADX (14)21
+DI / −DI25 / 14
RSI divergence—
MACD divergence—
ATR %+4.23%
ADR %3.66%
52w high76.78
52w low44.34
From 52w high-30.33%
Above 52w low+20.65%
New 52w highNo
SqueezeOff
Bollinger width19.02%
%B0.94
Donchian pos86.82%
Donchian high54.65
Donchian low45.89
AVWAP (52w high)55.02
vs AVWAP high-2.78%
AVWAP (52w low)52.44
vs AVWAP low+2.02%
OBV trendFlat
Chaikin MF (20)0.02
Today vs 20d0.96×
Avg vol (14d)1.59M
Avg vol (20d)1.6M
Avg $ vol (20d)79M
Market cap5.17B
RS 3m (vs SPY)-3.60%
RS 6m (vs SPY)+2.54%
RS line new highNo
Trend template2/8
Technical rank58.1
1 week+7.92%
1 month+0.27%
3 months-2.43%
6 months+9.76%
1 year-4.40%
YTD-0.51%
P/E-8.89
P/B2.96
P/S—
P/FCF-14.95
EPS-6.47
Div yield—
ROE-33.30%
ROA-21.94%
Debt/Eq0.34
Current17.85
EV/EBITDA-8.48
Gross margin—
Net margin—
Rev growth-90.59%
EPS growth-58.80%
Price target73.14
Target upside36.72%
Analyst ratingBuy
Institutional84.33%
Ent. value5.47B
Revenue10.18M
Net income-91.15M
Gross profit—
Free cash flow-345.93M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out96.45M
Employees393
ListedWed, Oct 19, 2016
Free float82.71M
Float %86.2%
Short interest19.81M
Days to cover11.6d
Short volume34.6%
Squeeze score65 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.94 vs −$1.10
Last surprise+14.6% beat
Setup gradeD
Conviction27 / 100
Pattern quality—
Tech rank58.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance60.68
Support49.60
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CRSP
No recent disclosed trades by Congress in CRSP. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CRSP · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Morrison Briggs Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 13K | $0 | 2026-06-05 | 2026-06-09 |
George Simeon Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 13K | $0 | 2026-06-05 | 2026-06-09 |
Behbahani Ali Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 13K | $0 | 2026-06-05 | 2026-06-09 |
Greene John Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 13K | $0 | 2026-06-05 | 2026-06-09 |
Treco Douglas A Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 13K | $0 | 2026-06-05 | 2026-06-09 |
Rommel Christian Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 13K | $0 | 2026-06-05 | 2026-06-09 |
Fleming Harold Edward Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 13K | $0 | 2026-06-05 | 2026-06-09 |
High Katherine A Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 13K | $0 | 2026-06-05 | 2026-06-09 |
Mahatme Sandesh Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 13K | $0 | 2026-06-05 | 2026-06-09 |
Fardis Maria Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 13K | $0 | 2026-06-05 | 2026-06-09 |
SEC filings
EDGAR filings in CRSP · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.